DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Joensuu H, Eriksson M, Hall KS et al.
Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib.
Cancer 2014;
120: 2325-2333
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.